123 related articles for article (PubMed ID: 10509302)
1. Hyperinsulinemia in polycystic ovary disease.
Arthur LS; Selvakumar R; Seshadri MS; Seshadri L
J Reprod Med; 1999 Sep; 44(9):783-7. PubMed ID: 10509302
[TBL] [Abstract][Full Text] [Related]
2. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
3. Impaired glucose tolerance is associated with changes in clinical and biochemical parameters in women with polycystic ovary syndrome.
Walch K; Grimm C; Nagele F; Huber J; Wölfler M; Vytiska-Binstorfer E; Unfried G; Hefler L
Acta Obstet Gynecol Scand; 2006; 85(7):869-73. PubMed ID: 16817088
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance in polycystic ovary syndrome.
Prelevic GM
Curr Opin Obstet Gynecol; 1997 Jun; 9(3):193-201. PubMed ID: 9263704
[TBL] [Abstract][Full Text] [Related]
5. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin in clomiphene responders and nonresponders with polycystic ovarian disease.
Espinosa de los Monteros A; Ayala J; Sanabria LC; Parra A
Rev Invest Clin; 1995; 47(5):347-53. PubMed ID: 8584804
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous glucose tolerance test in the polycystic ovary syndrome].
Relli P; Cotrozzi G; Matteini M; Lazzari T; Bufalini GN
Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1451-4. PubMed ID: 6762217
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
9. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
Yilmaz M; Karakoç A; Törüner FB; Cakir N; Tiras B; Ayvaz G; Arslan M
Gynecol Endocrinol; 2005 Sep; 21(3):154-60. PubMed ID: 16335907
[TBL] [Abstract][Full Text] [Related]
10. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome.
Fulghesu AM; Angioni S; Portoghese E; Milano F; Batetta B; Paoletti AM; Melis GB
Fertil Steril; 2006 Aug; 86(2):398-404. PubMed ID: 16769061
[TBL] [Abstract][Full Text] [Related]
11. [Oral glucose tolerance test in polycystic ovary syndrome].
Cotrozzi G; Matteini M; Relli P; Lazzari T; Bufalini GN
Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1446-50. PubMed ID: 6762216
[TBL] [Abstract][Full Text] [Related]
12. ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.
Uncu G; Ozyurek SE; Uncu Y
Fertil Steril; 2007 Sep; 88(3):670-4. PubMed ID: 17451692
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
Bahceci M; Aydemir M; Tuzcu A
Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
[TBL] [Abstract][Full Text] [Related]
14. Odd variation of 75 g oral glucose tolerance test results in a Japanese patient with polycystic ovary syndrome: a case report.
Takahashi K; Mutiara S; Kita N; Tsuji S; Noda Y; Miyazaki K
Arch Gynecol Obstet; 2007 May; 275(5):405-9. PubMed ID: 17103180
[TBL] [Abstract][Full Text] [Related]
15. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary disease. A risk factor for gestational diabetes?
Lanzone A; Caruso A; Di Simone N; De Carolis S; Fulghesu AM; Mancuso S
J Reprod Med; 1995 Apr; 40(4):312-6. PubMed ID: 7623362
[TBL] [Abstract][Full Text] [Related]
17. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome.
Noyan V; Yucel A; Sagsoz N
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):200-5. PubMed ID: 15262356
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome.
Ohgi S; Nakagawa K; Kojima R; Ito M; Horikawa T; Saito H
Fertil Steril; 2008 Aug; 90(2):373-7. PubMed ID: 17923132
[TBL] [Abstract][Full Text] [Related]
19. Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome.
Dahan MH; Goldstein J
Fertil Steril; 2006 Oct; 86(4):934-41. PubMed ID: 17027360
[TBL] [Abstract][Full Text] [Related]
20. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A
J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
